Evidence map›Paper›PMID 30297539›Full record

Observational studyJournal of neurointerventional surgery2019

SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results.

Laurent Pierot, Laurent Spelle, Jérôme Berge, Anne-Christine Januel, Denis Herbreteau, Mohamed Aggour, Michel Piotin, Alessandra Biondi, Xavier Barreau, Charbel Mounayer and 6 more

2 registry-linked trialsAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of neurointerventional surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02921698 completednot on this map

Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment

Typeobservational_patient_registrySponsorMicrovention-Terumo, Inc.Ran2014 to 2017Enrolled100ConditionsIntracranial AneurysmsArmsFRED®
NCT06416657 narecruitingnot on this mapstarted 2024, after this paper: background citation

General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter: an Exploratory Randomized Clinical Trial

TypeinterventionalSponsorMing LvRan2024 to 2026Enrolled188ConditionsIntracranial AneurysmArmsDifferent anesthesia methods, namely local anesthesia and general anesthesia
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: A systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Determining flow stasis zones in the intracranial aneurysms and the relation between these zones and aneurysms' aspect ratios after flow diversions.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  15. Treatment outcomes and effectiveness of FRED for fusiform vertebral artery aneurysms.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  16. Article
  17. Article
  18. Observational
  19. Multicenter analysis of the incidence of in-stent stenosis following the deployment of flow-redirection endoluminal device in the treatment of intracranial aneurysms.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laurent PierotHôpital Maison-Blanche, Université Reims-Champagne-Ardenne, Reims, France.
Laurent SpelleParis-Saclay University, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jérôme BergeCHU Pellegrin, Bordeaux, France.
Anne-Christine JanuelCHU Toulouse, Toulouse, France.
Denis HerbreteauHôpital Bretonneau, Université François Rabelais, Tours, France.
Mohamed AggourCHU Saint-Etienne, Saint-Etienne, France.
Michel PiotinFondation Ophtalmologique A. de Rothschild, Paris, France.
Alessandra BiondiHôpital Jean-Minjoz, CHRU de Besançon, Besançon, France.
Xavier BarreauCHU Pellegrin, Bordeaux, France.ORCID http://orcid.org/0000-0002-4932-1484
Charbel MounayerCHU Dupuytren, Limoges, France.
Chrisanthi PapagiannakiHôpital Charles Nicolle, Université de Rouen, Rouen, France.ORCID http://orcid.org/0000-0002-9473-9644
Jean-Paul LejeuneCHU Lille, Lille, France.
Jean-Yves GauvritCHU Rennes, Rennes, France.
Anne-Laure DerelleCHU Nancy, Nancy, France.
Emmanuel ChabertCHU Clermont-Ferrand, Clermont-Ferrand, France.
Vincent CostalatHôpital Gui de Chauliac, Université de Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeFlow diversion is an innovative and increasingly used endovascular treatment for intracranial aneurysms. Its initial evaluation with the first devices available showed good efficacy of this treatment with variable safety results. The Flow Direction Endoluminal Device (FRED) has a specific design and was evaluated in a single-arm, multicenter, prospective, Good Clinical Practice study: SAFE (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment). This analysis reports clinical results at 1 year and anatomical results at 6 months and 1 year.

methodsPatients with unruptured and recanalized aneurysms located in the anterior circulation treated with FRED and FRED Jr were prospectively included. A Clinical Event Committee and a Core Laboratory independently evaluated clinical outcome and anatomical results.

resultsThirteen interventional neuroradiology centers included 103 patients/aneurysms. Aneurysm locations were supraclinoid internal carotid artery (ICA) in 71 (68.9%), cavernous ICA in 15 (14.6%), anterior cerebral or anterior communicating artery in 9 (8.7%), and middle cerebral artery in 8 (7.8%). Most aneurysms were small (<10 mm) in 71 patients (68.9%). Cumulative 1-year mortality and morbidity rates were 2/103 (1.9%) and 3/103 (2.9%), respectively, one death being related to cancer. At 1 year, anatomical results were: complete occlusion in 66/90 patients (73.3%), neck remnant in 7/90 patients (7.8%), and aneurysm remnant in 17/90 patients (18.9%).

conclusionsSAFE study analysis at 1 year confirms the excellent safety profile of the FRED device for aneurysm treatment, with low morbidity and mortality rates (2.9% and 1.9%, respectively) and demonstrates its efficacy (adequate occlusion in 73/90 (81.1%)). CLINICAL

trial registrationUnique identifier: NCT02921698; Results.

Indexed as

Self Expandable Metallic StentsAdultAgedAged, 80 and overEmbolization, TherapeuticEndovascular ProceduresFemaleHumansIntracranial AneurysmMaleMiddle AgedProspective StudiesTreatment Outcomeaneurysmflow diverter

Identifiers

PMID30297539
PMCPMC6582717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.